WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced today that the National Institute on Drug Abuse (NIDA) has awarded a grant totaling $185,413 to the University of New England (UNE). The grant will help fund research into the therapeutic potential of interferon (IFN)-beta for HIV-associated neurocognitive disorders in opioid users.
“The opioid abuse crisis and the effects of addiction are devastating communities in Maine and around the country. It is critical that we continue to support research that tests new and innovative therapies,” Senators Collins and King said in a joint statement. “By better understanding the science behind addiction, HIV, and neurocognitive disorders, we can help save lives and strengthen the health and safety of our communities.”
The National Institute on Drug Abuse (NIDA) is administered by the National Institutes of Health, an agency of the Department of Health and Human Services (HHS). NIDA works to advance national scientific research on addiction and drug abuse.